Glycekare is Medley’s focused initiative addressing the growing burden of Type 2 Diabetes Mellitus (T2DM) in India. With a wide portfolio of clinically relevant and patient-aligned therapies, Glycekare is on a mission to support Clinicians with solutions that align with evolving reatment goals and patient needs.
The prevalence of diabetes is increasing rapidly across India. T2DM is associated with multiple metabolic challenges including postprandial hyperglycaemia, insulin resistance, progressive beta-cell dysfunction and long-term risks to cardiovascular and renal health. Effective management requires a multifactorial approach that addresses these interconnected concerns.
At Glycekare, every product is developed with a strong pharmacological foundation and guided by national and international diabetes guidelines.
At Glycekare, every product is developed with a strong pharmacological foundation and guided by national and international diabetes guidelines.
In addition to IDA, the increasing prevalence of respiratory illnesses, gut health disorders, and bacterial infections continues to impact the overall quality of life. Nutrakare aims to tackle these challenges with a broad and growing portfolio.
A fast-acting combination design to tackle post-meal glucose spikes, especially relevant for Indian carbohydrate-rich diets. It is India’s first fixed-dose combination in this class and the No.1 formulation for postprandial blood glucose (PPBG) control.
A triple drug formulation that targets insulin resistance, enhances insulin secretion and delays carbohydrate absorption.
Offering glycaemic control along with cardiorenal protection. Its combinations are developed to meet the diverse and advanced needs of Indian diabetic patients. A unique patient centric: Sugar Kumar is integrated for bridging the current gap of practicing clinicians & patients on diabetes counselling (education & awareness)
For more information, clinical support, or to explore our full portfolio of diabetes therapies, connect with the Glycekare team.
We are committed to empowering clinicians and enhancing patient outcomes in everyday practice.
Company Identification Number
( CIN ) : U24230MH1975PLC018296
Medley House, D2,
M.I.D.C. Area,
Andheri (East),
Mumbai-400 093, INDIA
